GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Price-to-Operating-Cash-Flow

GeneOne Life Science (XKRX:011000) Price-to-Operating-Cash-Flow : (As of May. 12, 2024)


View and export this data going back to 1987. Start your Free Trial

What is GeneOne Life Science Price-to-Operating-Cash-Flow?

As of today (2024-05-12), GeneOne Life Science's share price is ₩2375.00. GeneOne Life Science's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-279.85. Hence, GeneOne Life Science's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for GeneOne Life Science's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, GeneOne Life Science's highest Price-to-Operating-Cash-Flow Ratio was 111.34. The lowest was 22.09. And the median was 57.86.

XKRX:011000's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 26.92
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

GeneOne Life Science's Cash Flow from Operations per share for the three months ended in Dec. 2023 was ₩-53.07. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-279.85.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -8.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -24.10% per year.

During the past 13 years, GeneOne Life Science's highest 3-Year average Operating Cash Flow per Share Growth Rate was 54.50% per year. The lowest was -107.40% per year. And the median was 0.05% per year.


GeneOne Life Science Price-to-Operating-Cash-Flow Historical Data

The historical data trend for GeneOne Life Science's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneOne Life Science Price-to-Operating-Cash-Flow Chart

GeneOne Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

GeneOne Life Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of GeneOne Life Science's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, GeneOne Life Science's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GeneOne Life Science's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, GeneOne Life Science's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where GeneOne Life Science's Price-to-Operating-Cash-Flow falls into.



GeneOne Life Science Price-to-Operating-Cash-Flow Calculation

GeneOne Life Science's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=2375.00/-279.852
=

GeneOne Life Science's Share Price of today is ₩2375.00.
GeneOne Life Science's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-279.85.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

GeneOne Life Science Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of GeneOne Life Science's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


GeneOne Life Science (XKRX:011000) Business Description

Traded in Other Exchanges
N/A
Address
343, Hakdong-ro, Gangnam-Gu, Seoul, KOR
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.

GeneOne Life Science (XKRX:011000) Headlines

No Headlines